Skip to main content

Betreuung schwangerer und stillender Patientinnen — Psychopharmakotherapie und psychiatrische Begleitung

  • Chapter
Psychiatrie und Psychotherapie
  • 11k Accesses

Zusammenfassung

Die Behandlung psychisch kranker Frauen in Schwangerschaft und Stillzeit ist eine eher seltene Aufgabe für klinisch tätige oder auch niedergelassene Psychiater; vielleicht liegt darin der Grund, warum eine erste und typische Reaktion zunächst die Verunsicherung aller Beteiligten ist. Und natürlich haben wir alle auf dem Hintergrund der Contergan-Affäre in den 1960er Jahren gelernt, welche gravierenden Probleme teratogene Substanzen verursachen können. Ein verantwortlicher Umgang mit Psychopharmaka in der Schwangerschaft ist die erfreuliche Konsequenz dieser Erfahrungen. Andererseits aber gibt es auch immer wieder Situationen, in denen vorschnelle Handlungen — wie ein abruptes Absetzen oder Umsetzen der Medikation — eine Patientin ohne Not psychisch destabilisieren. Die Prinzipien der Behandlung von Frauen, die eine Schwangerschaft planen oder auch ungeplant schwanger sind, werden im folgenden Kapitel dargestellt, ergänzt durch Informationen zur Stillzeit. Diese Hinweise ersetzen jedoch nicht die sorgfältige Information und Abwägung in jedem Einzelfall.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adab N, Jacoby A, Smith D et al. (2001) Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosur Psychiat 70: 15–21

    Article  CAS  Google Scholar 

  • Adab N, Kini U, Vinten J et al. (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosur Psychiat 75: 1575–1583

    Article  CAS  Google Scholar 

  • Brockington I (2004) Postpartum psychiatric disorders. Lancet 363: 303–310

    Article  PubMed  Google Scholar 

  • Chambers CD, Hernandez-Diaz S, Van Marter LJ et al. (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354: 579–587

    Article  PubMed  CAS  Google Scholar 

  • Cunnington M, Ferber S, Quartey G, International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2007) Effect of dose on the frequency of major birth defects following fetal exposure to lamotrigine monotherapy in an international observational study. Epilepsia 48: 1207–1210

    Article  PubMed  CAS  Google Scholar 

  • Dansky LV, Finnell RH (1991) Parental epilepsy, anticonvulsant drugs and reproductive outcome: epidemiologic and experimental findings spanning three decades: 2. Human studies. Reprod Toxicol 5: 301–335

    Article  PubMed  CAS  Google Scholar 

  • Frassetto F, Martel FT, Barjhoux CE et al. (2002) Goiter in a newborn exposed to lithium in utero. Ann Pharmacother 36: 1745–1748

    Article  PubMed  Google Scholar 

  • Gentile S (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Safety 28: 137–152

    Article  PubMed  CAS  Google Scholar 

  • Grof P, Robbins W, Berghoefer A et al. (2002) Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 61: 31–39

    Article  Google Scholar 

  • Hallberg P, Sjöblom V (2005) The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. J Clin Psychopharmacol 25: 59–73

    Article  PubMed  CAS  Google Scholar 

  • Holmes LB, Wyszynski DF, Baldwin EJ et al. (2006) Increased risk for non syndromic cleft palate among infants exposed to lamotrigine during pregnancy (Abstract). Birth Defects Res Part A, 76: 318

    Google Scholar 

  • Howard LM, Goss C, Leese M, Thornicroft G (2003) Medical outcome of pregnancy in women with psychotic disorders and their infants in the first year after birth. Br J Psychiatry 182: 63–67

    Article  PubMed  Google Scholar 

  • Källén B, Otterblad Olausson P (2006) Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 21: 221–222

    Article  PubMed  CAS  Google Scholar 

  • Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of Puerperal Psychoses 150: 662–673

    CAS  Google Scholar 

  • Llewellyn A, Stowe ZN, Strader JR (1998) The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 59: 57–64

    PubMed  CAS  Google Scholar 

  • Loebstein R, Lalkin A, Koren G (1997) Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33: 328–343

    Article  PubMed  CAS  Google Scholar 

  • Matalon S, Schechtman S, Goldzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 16: 9–17

    Article  PubMed  CAS  Google Scholar 

  • McKenna K, Koren G, Tetelbaum M et al (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66: 444–449

    Article  PubMed  CAS  Google Scholar 

  • Morrow J, Russell A, Guthrie E (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosur Psychiat 77: 193–198

    Article  CAS  Google Scholar 

  • Murray L, Cooper PJ, Wilson A, Romaniuk H (2003) Controlled trial of the short-and long-term effect of psychological treatment of post-partum depression — 2. Impact on the mother-child realtionship and child outcome. Br J Psychiatry 82: 420–427

    Article  Google Scholar 

  • Nulman I, Rovet J, Stewart DE et al. (2002) Child development following exposure to tricyclic antidepressants or fluoxetin throughout fetal life: a prospective study. Am J Psychiatry 159: 1889–1995

    Article  PubMed  Google Scholar 

  • Rohde A (2007) Psychisch kranke Schwangere — Peripartales Management. Psychoneuro 33: 128–131

    Article  Google Scholar 

  • Schaefer C, Spielmann H, Vetter K (2006) Arzneiverordnung in Schwangerschaft und Stillzeit, 7. Aufl. Elsevier/Urban & Fischer, München

    Google Scholar 

  • Shepard TH, Brent RL, Friedman JM et al. (2002) Update on new developments in the study of human teratogens. Teratology 65: 153–161

    Article  PubMed  CAS  Google Scholar 

  • Viguera AC, Nonacs R, Cohen LS et al. (2000) Risk of Recurrence of Bipolar Disorder in Pregnant and Nonpregnant Women after Discontinuing Lithium Maintenance. Am J Psychiatry 157: 179–184

    Article  PubMed  CAS  Google Scholar 

  • Viguera AC, Cohen LS, Baldessarini RJ, Nonacs R (2002) Managing Bipolar Disorder During Pregnancy: Weighing in the risks and benefits. Can J Psychiatry 47: 426–436

    PubMed  Google Scholar 

  • Williams G, King J, Cunningham M et al. (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43: 202–206

    Article  PubMed  CAS  Google Scholar 

  • Zeskind PS, Stephens LE (2004) Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113: 368–375

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Rohde, A., Schaefer, C. (2008). Betreuung schwangerer und stillender Patientinnen — Psychopharmakotherapie und psychiatrische Begleitung. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33129-2_75

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33129-2_75

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24583-4

  • Online ISBN: 978-3-540-33129-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics